Envoy Medical (COCH) Projected to Post Quarterly Earnings on Wednesday

Envoy Medical (NASDAQ:COCH) will likely be posting its quarterly earnings results before the market opens on Wednesday, May 21st. Analysts expect Envoy Medical to post earnings of ($0.35) per share and revenue of $0.09 million for the quarter.

Envoy Medical (NASDAQ:COCH) last announced its earnings results on Friday, March 28th. The company reported ($0.45) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.12). The firm had revenue of $0.04 million during the quarter, compared to analysts’ expectations of $0.07 million. On average, analysts expect Envoy Medical to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Envoy Medical Stock Performance

NASDAQ COCH opened at $1.62 on Wednesday. The business’s 50 day moving average price is $1.39 and its 200-day moving average price is $1.64. Envoy Medical has a fifty-two week low of $1.21 and a fifty-two week high of $3.99. The company has a market cap of $34.55 million, a P/E ratio of -1.17 and a beta of 2.33.

Analyst Ratings Changes

Separately, Ascendiant Capital Markets raised their target price on shares of Envoy Medical from $9.00 to $9.25 and gave the stock a “buy” rating in a report on Monday, April 21st.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.